CN101843700A - Chinese medicament for treating coronary disease - Google Patents

Chinese medicament for treating coronary disease Download PDF

Info

Publication number
CN101843700A
CN101843700A CN200910235494A CN200910235494A CN101843700A CN 101843700 A CN101843700 A CN 101843700A CN 200910235494 A CN200910235494 A CN 200910235494A CN 200910235494 A CN200910235494 A CN 200910235494A CN 101843700 A CN101843700 A CN 101843700A
Authority
CN
China
Prior art keywords
parts
chinese medicine
chinese
rehmannia
chinese medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200910235494A
Other languages
Chinese (zh)
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lvyuan Qiuzheng Technology Development Co Ltd
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN200910235494A priority Critical patent/CN101843700A/en
Publication of CN101843700A publication Critical patent/CN101843700A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a Chinese medicament for treating a coronary disease, and belongs to the field of Chinese medicaments for treating cardio-cerebral-vascular system diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: peach seed, radix pseudo-ginseng, white paeony root, Szechuan lovage rhizome, root of rehmannia, lucid ganoderma and Chinese angelica. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and yin, activating blood and dissolving stasis, and nourishing heart and soothing nerves, and has the advantages of obvious effect, exact medicinal effect and quick response.

Description

一种治疗冠心病的中药 Chinese medicine for treating coronary heart disease

技术领域technical field

本发明属于治疗心脑血管系统疾病的中药领域。The invention belongs to the field of traditional Chinese medicine for treating diseases of the cardiovascular and cerebrovascular systems.

背景技术Background technique

目前旨在治疗冠心病的中药领域,存在两个方面的不足:一是效果不够明显,二是见效比较迟缓。许多冠心病患者长期忍受胸闷胸痛的折磨,面临心肌梗死的危险,患者及其家属对此不够满意。At present, there are two deficiencies in the field of traditional Chinese medicine aimed at treating coronary heart disease: one is that the effect is not obvious enough, and the other is that the effect is relatively slow. Many patients with coronary heart disease suffer from chest tightness and chest pain for a long time, and face the risk of myocardial infarction. Patients and their families are not satisfied with this.

针对以上提出的问题,本发明提供一种治疗冠心病的中药,它能解决以往此类中药效果不够明显,见效比较迟缓的问题,效果好、见效快,具有效果显著,药效确切,见效较快的优点。In view of the above problems, the present invention provides a traditional Chinese medicine for the treatment of coronary heart disease, which can solve the problem that the effect of traditional Chinese medicines is not obvious enough, and the effect is relatively slow. The advantage of being fast.

发明内容Contents of the invention

本发明是通过以下技术方案来实现的:The present invention is achieved through the following technical solutions:

1、一种治疗冠心病的中药,采用中药原料制备,配方为(按重量比):1, a kind of Chinese medicine for the treatment of coronary heart disease, adopts Chinese medicine raw material to prepare, and formula is (by weight):

桃仁4-30份    三七3-25份    白芍3-25份4-30 parts of peach kernel 3-25 parts of panax notoginseng 3-25 parts of white peony root

川芎4-30份    生地4-30份    灵芝2-15份Chuanxiong 4-30 parts Rehmannia 4-30 parts Ganoderma lucidum 2-15 parts

当归3-25份Angelica 3-25 servings

这种治疗冠心病的中药是由下列方法制成的:This traditional Chinese medicine for treating coronary heart disease is made by the following methods:

(1)按上述重量比,将桃仁、白芍、川芎、生地、当归经常规水提取工艺提取,制成浸膏细粉;(1) according to the above weight ratio, peach kernel, Radix Paeoniae Alba, Rhizoma Chuanxiong, Rehmannia Radix, Radix Angelicae Sinensis are extracted through conventional water extraction process to make extractum fine powder;

(2)按上述重量比,将三七、灵芝分别研成细粉,与上述浸膏细粉混合,搅拌均匀;根据需要,可制成中药冲剂、颗粒剂、散剂、胶囊剂、水丸剂、片剂等剂型。(2) According to the above weight ratio, grind Panax notoginseng and Ganoderma lucidum into fine powder respectively, mix with the above-mentioned extract powder, and stir evenly; as required, it can be made into Chinese medicine granules, granules, powders, capsules, water pills, Dosage forms such as tablets.

本发明是根据民间传统配方,根据中医扶正培本、活血化瘀的理论,精心研制而成。中医认为,冠心病心绞痛多属气阴两虚、心脉瘀阻,只当益气养阴,活血化瘀。方中灵芝益气补血,养心安神,扶正培本,此为主药;合生地、白芍益气养阴;当归、川芎、桃仁活血化瘀;佐以三七化瘀止痛。诸药配伍,相得益彰,共奏扶正培本,益气养阴,活血化瘀,养心安神之功,效果好,见效快,具有效果显著,药效确切,见效较快的优点。The present invention is elaborately developed according to the folk traditional formula and the theory of traditional Chinese medicine of strengthening the body and strengthening the body, promoting blood circulation and removing blood stasis. Traditional Chinese medicine believes that angina pectoris caused by coronary heart disease is mostly due to deficiency of both qi and yin, and stasis of the heart arteries. In the prescription, Ganoderma lucidum nourishes qi and blood, nourishes the heart and calms the nerves, strengthens the body and cultivates the root, this is the main drug; Heshengdi, Baishao nourishes qi and nourishes yin; Angelica, Chuanxiong, peach kernel promotes blood circulation and removes blood stasis; adjuvant with Panax notoginseng to remove blood stasis and relieve pain. All the medicines are compatible and complement each other. They play the functions of strengthening the body, nourishing qi and nourishing yin, promoting blood circulation and removing blood stasis, nourishing the heart and calming the nerves. The effect is good, and the effect is fast.

具体实施方式Detailed ways

通过以下实施方式对本发明做具体说明:The present invention is specifically described by the following embodiments:

1、取以下配方(重量按克为单位):1. Take the following formula (weight is in grams):

桃仁80克    三七60克    白芍60克80 grams of peach kernels 60 grams of Panax notoginseng 60 grams of white peony root

川芎80克    生地80克    灵芝40克Chuanxiong 80g Rehmannia 80g Ganoderma lucidum 40g

当归60克Angelica 60g

按规定重量,用常规水提取工艺将桃仁、白芍、川芎、生地、当归提取,制成浸膏细粉108克,将灵芝、三七分别研成细粉,与上述浸膏细粉混合,搅拌均匀,制成细小颗粒,装入0号胶囊,制成中药胶囊742粒,每粒胶囊内含中药细粉及提取物0.28克。According to the specified weight, peach kernel, white peony root, chuanxiong, rehmannia root, and angelica are extracted by conventional water extraction process to make 108 grams of extract powder, and Ganoderma lucidum and Panax notoginseng are respectively ground into fine powder, mixed with the above extract powder, Stir evenly, make fine particles, pack into No. 0 capsules, and make 742 Chinese medicine capsules, each capsule contains Chinese medicine fine powder and 0.28 grams of extract.

2、取以下配方(重量按克为单位):2. Take the following formula (weight is in grams):

桃仁150克    三七150克    白芍120克150 grams of peach kernels 150 grams of Panax notoginseng 120 grams of white peony

川芎150克    生地150克    灵芝100克Chuanxiong 150g Rehmannia 150g Ganoderma lucidum 100g

当归120克Angelica 120g

按上述同样的方法,制成中药胶囊1632粒,每粒胶囊内含中药细粉及提取物0.28克。By above-mentioned same method, make 1632 Chinese medicine capsules, every capsule contains Chinese medicine fine powder and extract 0.28 gram.

3、取以下配方(重量按克为单位):3. Take the following formula (the weight is in grams):

桃仁300克    三七250克    白芍250克300 grams of peach kernels 250 grams of Panax notoginseng 250 grams of white peony

川芎300克    生地300克    灵芝150克Chuanxiong 300g Rehmannia 300g Ganoderma lucidum 150g

当归250克Angelica 250g

按上述同样的方法,制成中药胶囊2928粒,每粒胶囊内含中药细粉及提取物0.28克。By above-mentioned same method, make 2928 Chinese medicine capsules, every capsule contains Chinese medicine fine powder and extract 0.28 gram.

4、取以下配方(按重量比):4. Take the following formula (by weight):

桃仁6份    三七4份    白芍5份6 parts peach kernel 4 parts Panax notoginseng 5 parts white peony root

川芎6份    生地6份    灵芝3份Chuanxiong 6 parts Rehmannia 6 parts Ganoderma lucidum 3 parts

当归5份Angelica 5 servings

按上述同样的方法,制成中药胶囊,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, Chinese medicine capsules are made, and each capsule contains 0.28 grams of Chinese medicine fine powder and extract.

5、取以下配方(按重量比):5. Take the following formula (by weight):

桃仁20份    三七20份    白芍20份20 parts peach kernel 20 parts Panax notoginseng 20 parts white peony root

川芎20份    生地20份    灵芝10份Chuanxiong 20 parts Rehmannia 20 parts Ganoderma lucidum 10 parts

当归15份Angelica 15 servings

按上述同样的方法,制成中药胶囊,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, Chinese medicine capsules are made, and each capsule contains 0.28 grams of Chinese medicine fine powder and extract.

临床资料:clinical information:

本发明以中医冠心病为例,经12例临床观察。选择中医诊断冠心病为标准:体质虚弱,肢软乏力,胸闷胸痛,头晕心慌,心电图检查心肌缺血。如上症状,即可确诊。在确诊观察的对象中,男性6例,女性6例,无其它严重疾病,年龄为47岁-81岁,平均年龄61.2岁。The present invention takes coronary heart disease of traditional Chinese medicine as an example, through 12 clinical observations. TCM diagnosis of coronary heart disease was selected as the standard: physical weakness, limb weakness, chest tightness and chest pain, dizziness and palpitation, and myocardial ischemia by electrocardiogram. The above symptoms can be diagnosed. Among the objects under confirmed observation, there were 6 males and 6 females, without other serious diseases, aged from 47 to 81 years old, with an average age of 61.2 years old.

疗效判定:Judgment of curative effect:

1、显效:体质增强,身上有劲,胸闷胸痛等心区不适明显缓解,心电图可见心肌供血明显改善。1. Significant effect: Physical fitness is enhanced, body is strong, chest pain and other discomfort in the heart area are significantly relieved, and the electrocardiogram shows that the blood supply to the myocardium is significantly improved.

2、有效:体质增强,胸闷胸痛等心区不适有所缓解。2. Effective: Physical fitness is enhanced, and discomfort in the heart area such as chest tightness and chest pain is relieved.

3、无效:病症无变化。3. Ineffective: no change in symptoms.

临床实验时,停服其它药物和保健营养品。服用本发明中药胶囊,观察3个月,为一个疗程。服用方法:每日3次,每次4粒胶囊,每粒胶囊内含中药细粉及提取物0.28克,饭后温开水送服,30天后症状即有缓解,服用3个月后,症状明显改善。临床实验的12人中,显效5人,有效6人,无效1人,总有效率91.6%。During the clinical trial, stop taking other medicines and health nutrition products. Take Chinese medicine capsule of the present invention, observe 3 months, be a course of treatment. Dosing method: 3 times a day, 4 capsules each time, each capsule contains 0.28g of fine powder and extract of traditional Chinese medicine, take it with warm water after meals, the symptoms will be relieved after 30 days, and the symptoms will be obvious after taking it for 3 months improve. Among the 12 people in the clinical trial, 5 people were markedly effective, 6 people were effective, and 1 person was ineffective, and the total effective rate was 91.6%.

Claims (1)

1.一种治疗冠心病的中药,采用中药原料制备,配方为(按重量比):1. a kind of Chinese medicine for the treatment of coronary heart disease, adopts Chinese medicine raw material to prepare, and formula is (by weight): 桃仁4-30份    三七3-25份    白芍3-25份4-30 parts of peach kernel 3-25 parts of panax notoginseng 3-25 parts of white peony root 川芎4-30份    生地4-30份    灵芝2-15份Chuanxiong 4-30 parts Rehmannia 4-30 parts Ganoderma lucidum 2-15 parts 当归3-25份Angelica 3-25 servings 这种治疗冠心病的中药是由下列方法制成的:This traditional Chinese medicine for treating coronary heart disease is made by the following methods: (1)按上述重量比,将桃仁、白芍、川芎、生地、当归经常规水提取工艺提取,制成浸膏细粉;(1) according to the above weight ratio, peach kernel, Radix Paeoniae Alba, Rhizoma Chuanxiong, Rehmannia Radix, Radix Angelicae Sinensis are extracted through conventional water extraction process to make extractum fine powder; (2)按上述重量比,将三七、灵芝分别研成细粉,与上述浸膏细粉混合,搅拌均匀;根据需要,可制成中药冲剂、颗粒剂、散剂、胶囊剂、水丸剂、片剂等剂型。(2) According to the above weight ratio, grind Panax notoginseng and Ganoderma lucidum into fine powder respectively, mix with the above-mentioned extract powder, and stir evenly; as required, it can be made into Chinese medicine granules, granules, powders, capsules, water pills, Dosage forms such as tablets.
CN200910235494A 2009-10-16 2009-10-16 Chinese medicament for treating coronary disease Pending CN101843700A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200910235494A CN101843700A (en) 2009-10-16 2009-10-16 Chinese medicament for treating coronary disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200910235494A CN101843700A (en) 2009-10-16 2009-10-16 Chinese medicament for treating coronary disease

Publications (1)

Publication Number Publication Date
CN101843700A true CN101843700A (en) 2010-09-29

Family

ID=42768636

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200910235494A Pending CN101843700A (en) 2009-10-16 2009-10-16 Chinese medicament for treating coronary disease

Country Status (1)

Country Link
CN (1) CN101843700A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102669348A (en) * 2012-05-20 2012-09-19 北京绿源求证科技发展有限责任公司 Nutrition food of heart nourishing tea granule for nourishing heart

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102669348A (en) * 2012-05-20 2012-09-19 北京绿源求证科技发展有限责任公司 Nutrition food of heart nourishing tea granule for nourishing heart
CN102669348B (en) * 2012-05-20 2013-06-12 北京绿源求证科技发展有限责任公司 Nutrition food of heart nourishing tea granule for nourishing heart

Similar Documents

Publication Publication Date Title
CN101843787B (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101843661A (en) Chinese medicament for treating angina
CN101843712B (en) Chinese medicament for treating angina
CN101843660B (en) Chinese medicament for treating tachycardia
CN101537121B (en) Chinese medicine for treating arteriosclerosis
CN101843717B (en) Chinese medicament for treating coronary disease
CN101850015B (en) Chinese medicament for treating arteriosclerosis
CN101843753B (en) Chinese medicament for treating angina
CN101843877B (en) Chinese medicament for treating liver cirrhosis
CN101843835B (en) Chinese medicament for treating coronary diseases
CN101843673B (en) Chinese medicament for treating arteriosclerosis
CN101850054B (en) Chinese medicament for treating diabetic heart diseases
CN101843645B (en) Chinese medicament for treating tachycardia
CN101843831B (en) Chinese medicament for treating diabetic cardiopathy
CN101843672B (en) Chinese medicament for treating arteriosclerosis
CN101879259B (en) Traditional Chinese medicine for treating pulmonary heart diseases
CN101843879B (en) Chinese medicament for treating liver cirrhosis
CN101843720B (en) Chinese medicament for treating angina
CN101843703B (en) Chinese medicament for treating liver cirrhosis
CN101849985B (en) Chinese medicament for treating tachycardia
CN101843745B (en) Chinese medicament for treating chronic hepatitis
CN101843796A (en) Chinese medicament for treating pulmonary heart diseases
CN101554412A (en) Traditional Chinese medicine for treating atrial fibrillation
CN101843832A (en) Chinese medicament for treating coronary disease
CN101843805A (en) Chinese medicament for treating diabetic cardiopathy

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20100929